A Department of Health and Human Services official delivered an ultimatum to Dr. Peter Marks: either resign or be fired.
Pantheon Vision has signed a deal with Eyedeal Medical to advance the manufacturing of its corneal implants for treating ...
FDA pick, a former Johns Hopkins surgeon, seen as a less controversial nomination than some of Trump's other HHS subagency ...
Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
The Food and Drug Administration (FDA) has cautioned those taking a libido-boosting herbal dietary supplement after an ...
Diopsys, Inc., a medical device manufacturer based in Middletown, Pennsylvania, will pay up to $14.25 million to resolve ...
DelveInsight's "VUITY Market Size, Forecast, and Market Insight Report" highlights the details around VUITY, which is a ...
An estimated 45 million Americans wear them—and this recall affects at least two very recognizable brand names for eyes.
The Laser Vision Correction Center of New Jersey recently announced it is the first practice in the state to offer the only treatment approved by the U.S. Food and Drug Administration for dry ...
The demand for Marks to resign comes as the FDA is bracing for steep cuts at the ... senior federal health official said. "It was Peter's vision that made that work possible," the official added.
Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells ...